Table 4.
Factor | Frequency* | % | β | SE | Wald (χ2) | p | OR [95% CI] |
---|---|---|---|---|---|---|---|
Antiviral | .441 | .225 | 3.84 | 0.0501 | |||
No | 31 | 21.08 | 0.413 [0.16, 0.966] | ||||
Yes | 116 | 78.91 | 2.318 [1.03, 6.17] | ||||
Antifungal | .633 | .246 | 6.61 | 0.0101 | |||
No | 30 | 20.41 | 0.281 [0.09, 0.70] | ||||
Yesv | 117 | 79.59 | 3.54 [1.42, 10.15] | ||||
Antibacterial | 1.03 | .531 | 3.78 | 0.0519 | |||
No | 11 | 7.48 | 0.12 [0.01, 0.68] | ||||
Yes | 136 | 92.52 | 7.89 [0.01, 146.86] | ||||
Platelet | .660 | .176 | 13.98 | 0.0002 | |||
≥43 K/ uL | 78 | 53.06 | 0.267 [0.13, 0.52] | ||||
< 43 K/uL | 69 | 46.94 | 3.74 [1.89, 7.59] | ||||
Creatinine | .663 | .198 | 11.166 | 0.0008 | |||
≤.9 mg/dL | 50 | 34.01 | 0.26 [0.11, 0.56] | ||||
> .9 mg/dL | 97 | 65.99 | 3.77 [1.77, 8.52] | ||||
Primary Cancer | 1.13 | .527 | 4.65 | 0.0311 | |||
Other | 13 | 8.84 | 0.10 [0.00, 0.54] | ||||
Leukemia, lymphoma, or multiple myeloma | 134 | 91.16 | 9.72 [1.83, 179.70] |
Clinical cut points (median clinical value of the entire population) used in classifying patients into categories: K/uL, thousand per microliter; mg/dL, milligram per deciliter